ReviewCells2022

Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy.

Manjari Kundu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.